Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 5 August 2005. doi:10.1136/thx.2005.043943
Thorax 2005;60:842-847
Copyright © 2005 BMJ Publishing Group Ltd & British Thoracic Society

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
thx.2005.043943v1
60/10/842    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johannessen, A
Right arrow Articles by Gulsvik, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johannessen, A
Right arrow Articles by Gulsvik, A

CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study

A Johannessen1, E R Omenaas1,3, P S Bakke1,2, A Gulsvik1,2

1 Institute of Medicine, University of Bergen, Bergen, Norway
2 Department of Thoracic Medicine, Haukeland University Hospital, N-5021 Bergen, Norway
3 Centre for Clinical Research, Haukeland University Hospital, N-5021 Bergen, Norway

Correspondence to:
Correspondence to:
MsA Johannessen
Institute of Medicine, University of Bergen, N-5021 Bergen, Norway; ane.johannessen{at}helse-bergen.no

Background: The Global Initiative for Obstructive Lung Disease (GOLD) has defined chronic obstructive pulmonary disease (COPD) as a post-bronchodilator ratio of forced expiratory volume in 1 second to forced vital capacity (FEV1/FVC) of <0.7. In the first general population based study to apply post-bronchodilator values, the prevalence and predictors of GOLD defined COPD were assessed and the implications of ß2 agonist reversibility testing examined.

Methods: Based on a random population sample, 2235 subjects (77%) aged 26–82 years performed spirometric tests before and 15 minutes after inhaling 0.3 mg salbutamol.

Results: The prevalence of GOLD defined COPD was 7.0% (95% confidence interval (CI) 5.9 to 8.0). This estimate was 27% lower than COPD defined without bronchodilatation. One percent of the population had severe or very severe COPD. Compared with women, men had 3.1 (95% CI 2.1 to 4.8) times higher odds for COPD. Subjects with a smoking history of more than 20 pack years had an odds ratio (OR) of 6.2 (95% CI 3.4 to 11.0) for COPD relative to never-smokers, while subjects older than 75 years had an OR of 18.0 (95% CI 9.2 to 35.0) relative to those below 45 years. Subjects with primary education only had an OR of 2.8 (95% CI 1.4 to 5.3) compared with those with university education. Subjects with body mass index (BMI) <20 kg/m2 were more likely than subjects with BMI 25–29.9 kg/m2 to have COPD (OR 2.4, 95% CI 1.1 to 5.3). The adjusted proportion of COPD attributable to smoking was 68%.

Conclusions: These results indicate that community programmes on prevention of COPD should focus on anti-smoking, nutritional aspects, and socioeconomic conditions. The effect of ß2 reversibility testing on prevalence estimates of COPD was substantial.


Abbreviations: BMI, body mass index; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity

Keywords: chronic obstructive pulmonary disease; prevalence; Global Initiative for Obstructive Lung Disease (GOLD); bronchodilatation; epidemiology




This article has been cited by other articles:


Home page
ChestHome page
A. Kainu, A. Lindqvist, S. Sarna, B. Lundback, and A. Sovijarvi
FEV1 Response to Bronchodilation in an Adult Urban Population
Chest, August 1, 2008; 134(2): 387 - 393.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
M Bednarek, J Maciejewski, M Wozniak, P Kuca, and J Zielinski
Prevalence, severity and underdiagnosis of COPD in the primary care setting
Thorax, May 1, 2008; 63(5): 402 - 407.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
G. Viegi, F. Pistelli, D. L. Sherrill, S. Maio, S. Baldacci, and L. Carrozzi
Definition, epidemiology and natural history of COPD
Eur. Respir. J., November 1, 2007; 30(5): 993 - 1013.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
N. Zhong, C. Wang, W. Yao, P. Chen, J. Kang, S. Huang, B. Chen, C. Wang, D. Ni, Y. Zhou, et al.
Prevalence of Chronic Obstructive Pulmonary Disease in China: A Large, Population-based Survey
Am. J. Respir. Crit. Care Med., October 15, 2007; 176(8): 753 - 760.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. G. Pillai, G. Zhu, A. Gulsvik, D. A. Lomas, and E. K. Silverman
SERPINE2 and COPD
Am. J. Respir. Crit. Care Med., October 1, 2007; 176(7): 726 - 726.
[Full Text] [PDF]


Home page
ThoraxHome page
A. Johannessen, E. R Omenaas, G. E. Eide, P. S Bakke, and A. Gulsvik
Feasible and simple exclusion criteria for pulmonary reference populations
Thorax, September 1, 2007; 62(9): 792 - 798.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
D. M. Mannino
Defining chronic obstructive pulmonary disease... and the elephant in the room
Eur. Respir. J., August 1, 2007; 30(2): 189 - 190.
[Full Text] [PDF]


Home page
Eur Respir JHome page
P. Shirtcliffe, M. Weatherall, S. Marsh, J. Travers, A. Hansell, A. McNaughton, S. Aldington, H. Muellerova, and R. Beasley
COPD prevalence in a random population survey: a matter of definition
Eur. Respir. J., August 1, 2007; 30(2): 232 - 239.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. T. Dransfield, G. R. Washko, M. G. Foreman, R. S. J. Estepar, J. Reilly, and W. C. Bailey
Gender Differences in the Severity of CT Emphysema in COPD
Chest, August 1, 2007; 132(2): 464 - 470.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
D. M Mannino, A Sonia Buist, and W. M Vollmer
Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function?
Thorax, March 1, 2007; 62(3): 237 - 241.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. de Marco, S. Accordini, I. Cerveri, A. Corsico, J. M. Anto, N. Kunzli, C. Janson, J. Sunyer, D. Jarvis, S. Chinn, et al.
Incidence of Chronic Obstructive Pulmonary Disease in a Cohort of Young Adults According to the Presence of Chronic Cough and Phlegm
Am. J. Respir. Crit. Care Med., January 1, 2007; 175(1): 32 - 39.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
D M Mannino
Underdiagnosed chronic obstructive pulmonary disease in England: new country, same story.
Thorax, December 1, 2006; 61(12): 1032 - 1034.
[Full Text] [PDF]


Home page
Eur Respir JHome page
R. J. Halbert, J. L. Natoli, A. Gano, E. Badamgarav, A. S. Buist, and D. M. Mannino
Global burden of COPD: systematic review and meta-analysis
Eur. Respir. J., September 1, 2006; 28(3): 523 - 532.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Johannessen, S. Lehmann, E. R. Omenaas, G. E. Eide, P. S. Bakke, and A. Gulsvik
Post-Bronchodilator Spirometry Reference Values in Adults and Implications for Disease Management
Am. J. Respir. Crit. Care Med., June 15, 2006; 173(12): 1316 - 1325.
[Abstract] [Full Text] [PDF]


Home page
DTBHome page
Beta2 agonist reversibility testing in COPD diagnosis
DTB, December 1, 2005; 43(12): 89 - 91.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 BMJ Publishing Group Ltd & British Thoracic Society